Kerstin Westritschnig
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms.
Journal: The Journal of allergy and clinical immunology
Published: December 11, 2017
Safety of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children: An Open-label, Randomized, Active-controlled, Phase 3 Study.
Journal: The Pediatric infectious disease journal
Published: April 26, 2017
Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children From a Japanese Encephalitis Virus-endemic Region.
Journal: The Pediatric infectious disease journal
Published: April 22, 2017
A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients.
Journal: Critical care (London, England)
Published: July 18, 2016
Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study.
Journal: Vaccine
Published: April 27, 2016
Efficacy of a travelers' diarrhea vaccine system in travelers to India.
Journal: Journal of travel medicine
Published: October 30, 2013
A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers.
Journal: Human vaccines & immunotherapeutics
Published: September 26, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026